Anika Therapeutics Stock Technical Analysis

ANIK Stock  USD 16.97  0.46  2.64%   
As of the 22nd of November, Anika Therapeutics shows the Standard Deviation of 4.16, mean deviation of 1.78, and Risk Adjusted Performance of (0.08). Anika Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Anika Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Anika, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Anika
  
Anika Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Anika Therapeutics Analyst Consensus

Target PriceAdvice# of Analysts
26.33Strong Buy2Odds
Anika Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Anika analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Anika stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Anika Therapeutics, talking to its executives and customers, or listening to Anika conference calls.
Anika Analyst Advice Details
Anika Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Anika Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Anika Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Anika Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Anika Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Anika Therapeutics Trend Analysis

Use this graph to draw trend lines for Anika Therapeutics. You can use it to identify possible trend reversals for Anika Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Anika Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Anika Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Anika Therapeutics applied against its price change over selected period. The best fit line has a slop of   0.16  , which may suggest that Anika Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 939.75, which is the sum of squared deviations for the predicted Anika Therapeutics price change compared to its average price change.

About Anika Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Anika Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Anika Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Anika Therapeutics price pattern first instead of the macroeconomic environment surrounding Anika Therapeutics. By analyzing Anika Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Anika Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Anika Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding73.780.978.7654.36
PTB Ratio1.81.511.561.73

Anika Therapeutics November 22, 2024 Technical Indicators

Most technical analysis of Anika help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Anika from various momentum indicators to cycle indicators. When you analyze Anika charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Anika Therapeutics November 22, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Anika stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Anika Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Anika Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Anika Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Anika Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anika Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Anika Stock please use our How to buy in Anika Stock guide.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anika Therapeutics. If investors know Anika will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anika Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.51)
Earnings Share
(6.64)
Revenue Per Share
11.139
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.04)
The market value of Anika Therapeutics is measured differently than its book value, which is the value of Anika that is recorded on the company's balance sheet. Investors also form their own opinion of Anika Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Anika Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anika Therapeutics' market value can be influenced by many factors that don't directly affect Anika Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anika Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anika Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anika Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.